Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: A meta-analysis.

Abstract

A meta-analysis was used to determine whether administering recombinant granulocyte colony-stimulating factor (rG-CSF) to neonates with bacterial septicemia reduces mortality. Five studies were identified, involving 73 rG-CSF recipients and 82 control subjects. Mortality was lower among the rG-CSF recipients (odds ratio, 0.17; CI, 0.03-0.70; P <.05… (More)

Topics

  • Presentations referencing similar topics